James River Group Holdings, Ltd. (JRVR) News
Filter JRVR News Items
JRVR News Results
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
JRVR News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest JRVR News From Around the Web
Below are the latest news stories about JAMES RIVER GROUP HOLDINGS LTD that investors may wish to consider to help them evaluate JRVR as an investment opportunity.
Are Options Traders Betting on a Big Move in James River Group (JRVR) Stock?Investors need to pay close attention to James River Group (JRVR) stock based on the movements in the options market lately. |
James River Completes Closing of Adverse Development Cover and Common Equity Investment with Cavello Bay Reinsurance LimitedPEMBROKE, Bermuda, Dec. 23, 2024 (GLOBE NEWSWIRE) -- James River Group Holdings, Ltd. (“James River” or the “Company”) (NASDAQ: JRVR) today announced the close of both the adverse development reinsurance agreement and $12.5 million common equity investment with Enstar subsidiary Cavello Bay Reinsurance Limited, as per the terms and agreements previously announced on November 11, 2024. About James River Group Holdings, Ltd. James River Group Holdings, Ltd. is a Bermuda-based insurance holding com |
James River Group Holdings Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsJames River Group Holdings ( NASDAQ:JRVR ) Third Quarter 2024 Results Key Financial Results Revenue: US$191.5m (down... |
James River Group Holdings Ltd (JRVR) Q3 2024 Earnings Call Highlights: Navigating Challenges ...Despite reporting a net loss, James River Group Holdings Ltd (JRVR) strengthens its financial position with strategic investments and robust growth in its E&S and Specialty Admitted segments. |
Enstar subsidiary signs ADC agreement with James RiverThis agreement is set to provide $75m of limit in excess of the existing $160m adverse development cover (ADC) reinsurance coverage provided earlier this year to James River. |
James River Group (JRVR) Reports Q3 Loss, Tops Revenue EstimatesJames River Group (JRVR) delivered earnings and revenue surprises of -212.12% and 3.51%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock? |
James River Group: Q3 Earnings SnapshotPEMBROKE, Bermuda (AP) — James River Group Holdings Ltd. (JRVR) on Monday reported a loss of $39.4 million in its third quarter. The Pembroke, Bermuda-based company said it had a loss of $1.10 per share. Losses, adjusted for non-recurring costs and to account for discontinued operations, came to 74 cents per share. |
James River Announces Third Quarter 2024 Results, Strategic ActionsPEMBROKE, Bermuda, Nov. 11, 2024 (GLOBE NEWSWIRE) -- James River Group Holdings, Ltd. ("James River" or the "Company") (NASDAQ: JRVR) today reported the following results for the third quarter 2024 as compared to the same period in 20231: Three Months EndedSeptember 30, Three Months EndedSeptember 30,($ in thousands, except for share data) 2024 per diluted share 2023 per diluted shareNet (loss) income from continuing operations available to common shareholders$(40,702) $(1.07) $21,097 $0.55 Net |
James River Group Holdings (NASDAQ:JRVR) shareholders have endured a 79% loss from investing in the stock five years agoLong term investing is the way to go, but that doesn't mean you should hold every stock forever. We really hate to see... |
James River Group Holdings (JRVR): Specialty Insurance Nano Cap with Strong Q2 PerformanceWe recently published a list of 7 Best Nano Cap Stocks To Invest In. In this article, we are going to take a look at where James River Group Holdings, Ltd. (NASDAQ:JRVR) stands against other best nano cap stocks to invest in. What Are the Small Cap Bulls Saying? In one of our recent articles […] |